David Rescott Analyst Performance

Senior Research Analyst - Medical Technology at Robert W. Baird

David Rescott is a stock analyst at Robert W. Baird, covering 8 publicly traded companies across a range of sectors. Over the past year, David Rescott has issued 19 stock ratings, including buy and hold recommendations. While full access to David Rescott's proprietary MarketBeat Analyst Rating is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights David Rescott's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Ratings, Coverage, and Performance Statistics

Analyst Rating

Subscribe to MarketBeat All Access for the analyst's recommendation accuracy rating MarketBeat

Average Return

00.00% 12-Month ROI

Success Rate

00.00% Profitable Ratings

Total Ratings

22 Last 4 Years

Buy Recommendations

77.27% 17 Buy Ratings

Companies Covered

8 Unique Companies

Ratings Distribution

Rating	Percentage	Count
Strong Buy	0.0%	0 ratings
Buy	77.3%	17 ratings
Hold	22.7%	5 ratings
Sell	0.0%	0 ratings

Out of 22 total stock ratings issued by David Rescott at Robert W. Baird, the majority (77.3%) have been Buy recommendations, followed by 22.7% Hold.

Best & Worst Calls

• Best Call

  000.0%

  PEN

  Sep 2021

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.
• Worst Call

  000.0%

  MDT

  Aug 2021

  Subscribe to MarketBeat All Access to get analyst recommendation ROI.

Exchange Coverage

Exchange	Percentage	Count
NYSE	62.5% of companies on NYSE	5 companies
NASDAQ	37.5% of companies on NASDAQ	3 companies

David Rescott, an analyst at Robert W. Baird, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector Icon	Sector	Percentage
	Medical 8 companies	100.0%

David Rescott of Robert W. Baird specializes in stock coverage within the Medical sector.

Coverage Industries

Industry	Percentage
MED INSTRUMENTS 4 companies	50.0%
MED PRODUCTS 3 companies	37.5%
MED/DENTAL - SUPP 1 company	12.5%

About David Rescott

David Rescott is Baird’s Senior Research Analyst covering Medical Technology. Prior to joining Baird in 2023, David served as an Equity Research Analyst covering U.S. Medical Supplies & Devices at Truist Securities and previously as an Associate. David also previously worked as an Associate covering Biomedical Devices and Services at Canaccord Genuity. David received a BS in Business Administration and French from State University of New York at Geneseo and a Master of Science in Finance from Vanderbilt University.

David Rescott's Ratings History at Robert W. Baird

Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 4 Years 5 Years All Time Time Frame

Start Date

End Date

All Ratings Strong Buy Buy Hold Sell Rating

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription

12-Month ROIUpgrade to All Access to use the All ROI Filter

Export to Excel

Company	Report Date	Action	Report Date Price	12-Month Price Target	Rating	12-Month Price & ROI	Details
MDT Medtronic	8/20/2025	Boost Price Target	$89.92	$96.00	Neutral	$0.00 00.00% ROI
PEN Penumbra	7/30/2025	Boost Price Target	$256.22	$285.00	Outperform	$0.00 00.00% ROI
PEN Penumbra	7/30/2025	Set Price Target	$253.08	$310.00	Buy	$0.00 00.00% ROI
EW Edwards Lifesciences	7/25/2025	Boost Price Target	$75.68	$79.00	Neutral	$0.00 00.00% ROI
BSX Boston Scientific	7/24/2025	Boost Price Target	$107.51	$123.00	Outperform	$0.00 00.00% ROI
HAE Haemonetics	6/26/2025	Initiated Coverage	$73.52	$87.00	Outperform	$0.00 00.00% ROI
MDT Medtronic	5/22/2025	Lower Price Target	$81.62	$92.00	Neutral	$0.00 00.00% ROI
LIVN LivaNova	5/8/2025	Boost Price Target	$43.51	$61.00	Outperform	$0.00 00.00% ROI
MMSI Merit Medical Systems	4/25/2025	Lower Price Target	$94.67	$110.00	Outperform	$0.00 00.00% ROI
PEN Penumbra	4/24/2025	Boost Price Target	$278.18	$325.00	Outperform	$0.00 00.00% ROI
EW Edwards Lifesciences	4/24/2025	Boost Price Target	$70.33	$75.00	Neutral	$0.00 00.00% ROI
BSX Boston Scientific	4/24/2025	Boost Price Target	$99.01	$120.00	Outperform	$0.00 00.00% ROI
PEN Penumbra	4/24/2025	Boost Price Target	$291.34	$330.00	Buy	$0.00 00.00% ROI
ISRG Intuitive Surgical	4/23/2025	Lower Price Target	$478.74	$575.00	Outperform	$0.00 00.00% ROI
PEN Penumbra	4/11/2025	Lower Price Target	$267.12	$315.00	Buy	$0.00 00.00% ROI
ISRG Intuitive Surgical	3/18/2025	Lower Price Target	$488.80	$600.00	Outperform	$0.00 00.00% ROI
PEN Penumbra	2/19/2025	Boost Price Target	$270.99	$328.00	Outperform	$0.00 00.00% ROI
MDT Medtronic	2/19/2025	Boost Price Target	$86.05	$91.00	Neutral	$0.00 00.00% ROI
PEN Penumbra	2/19/2025	Boost Price Target	$307.06	$325.00	Buy	$0.00 00.00% ROI

Stock Forecasts and Research Tools

Sign in to your free account to enjoy these benefits

• In-depth profiles and analysis for 20,000 public companies.
• Real-time analyst ratings, insider transactions, earnings data, and more.
• Our daily ratings and market update email newsletter.

Sign in to your free account to enjoy all that MarketBeat has to offer.

• Sign In
• Create Account

Your Email Address:

Email Address Required

Your Password:

Password Required

Log In

---

or

Sign in with Facebook Sign in with Google

Forgot your password?

Your Email Address:

Please enter your email address.

Please enter a valid email address

Choose a Password:

Please enter your password.

Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character.

Create My Account (Free)

---

or

Sign in with Facebook Sign in with Google

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.